The new oral drug has been developed by a pharmaceutical company and its phase I of trial was earlier conducted in the USA. A similar study on phase II was also in progress at Kala-azar Medical Research Centre (KAMRC), Muzaffarpur, by a team led by Prof Shyam Sundar.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2pbn6qK
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
» Second phase of trial of new kala-azar drug in progress at RMRIMS
https://ift.tt/7MUD2TL
No comments:
Post a Comment